Description
GLP-1 Peptide
Retatrutide is a synthetic peptide engineered as a triple agonist, engaging GIP, GLP-1, and glucagon receptor pathways in a single molecule. Studied in metabolic research alongside dual-agonist compounds to compare receptor-combination effects on energy-balance signaling.
Specifications
| Format | Lyophilized powder |
| Purity | ≥99% (HPLC verified) |
| Storage | -20°C lyophilized, protected from light and moisture; 2-8°C after reconstitution |
✓ Certificate of Analysis available for this production lot — view our testing process
In the Lab
Retatrutide takes the dual-agonist idea and adds a third receptor, glucagon, on top of GIP and GLP-1. Researchers use it to see what changes once all three energy-balance pathways are engaged together — it’s the natural next comparison point after studying dual agonists.
Reviews
There are no reviews yet.